nPKCdelta a new therapeutic marker for melanoma metastasis? (Review).

  • Authors:
    • C A La Porta
  • View Affiliations

  • Published online on: Monday, May 1, 2000
  • Pages: 467-538
  • DOI: 10.3892/ijmm.5.5.467

Abstract

Melanoma metastasis is almost uniformly fatal. The identification of signal transduction as crucial effectors for tumorigenesis suggests modalities of gene therapy as well as design of specific drugs. the possible use of nPKCdelta as a therapeutic target is reviewed and discussed. Motivated by recent results, we propose a model in which nPKCdelta modulates melanin synthesis as well as metastasis.
Journal Cover

May 2000
Volume 5 Issue 5

Print ISSN: 1107-3756
Online ISSN:1791-244X

2013 Impact Factor: 1.88
Ranked #27/122 Medicine Research and Experimental
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
& La Porta, C. (2000). nPKCdelta a new therapeutic marker for melanoma metastasis? (Review).. International Journal of Molecular Medicine, 5(5), 467-538.
MLA
and C A La Porta. "nPKCdelta a new therapeutic marker for melanoma metastasis? (Review).." International Journal of Molecular Medicine International Journal of Molecular Medicine 5.5 (2000): 467-538.
Chicago
and C A La Porta. "nPKCdelta a new therapeutic marker for melanoma metastasis? (Review).." International Journal of Molecular Medicine International Journal of Molecular Medicine 5 no. 5 (2000): 467-538.